Sort
172,184 grants matching “inflammation”
Mammalian Glycosyltransferases for use in Chemistry and Biology
$1,501,275Geert-Jan Boons · University Of Georgia · P01 · FY2013 · GM
Stress Mechanisms Increasing Risk of Mood-Disorders
$1,500,907Charles Chavkin · University Of Washington · P50 · FY2019 · MH
Discovery of Drugs that Modulate Neuroinflammation for the treatment of Alzheimer's Disease
$1,500,781Kevin Hodgetts · Brigham And Women'S Hospital · U01 · FY2023 · AG
Michigan Center on Lifestage Environmental Exposures and Disease
$1,500,595Rita Karen Loch-Caruso · University Of Michigan At Ann Arbor · P30 · FY2018 · ES
Innovative Deep Phenotyping of African Americans at Risk for Alzheimers disease
$1,500,426David Loewenstein · University Of Miami School Of Medicine · R01 · FY2024 · AG
SUPPLEMENTAL WORK - SARS-COV-2 PRECLINICAL WORK
$1,500,152Laurie Sower · Chrysalis Biotherapeutics, Inc. · N01 · FY2020 · AI
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis
$1,500,001Robert M Plenge · Brigham And Women'S Hospital · U01 · FY2010 · GM
SBIR Phase II: Nanotechnology-Enabled Implant for Controlling Intraocular Pressure
$1,500,000Georgia E Griggs · Avisi Technologies, Inc · · FY2020 · TIP
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
$1,500,000Steven E Shoelson · Joslin Diabetes Center · U01 · FY2006 · DK
IND, FIH study and 3-month tox for PTI-125, a novel therapeutic for Alzheimer's disease
$1,500,000Lindsay H Burns · Cassava Sciences, Inc · R44 · FY2017 · AG
IND- and NDA-enabling toxicology studies for PTI-125, a novel small molecule for Alzheimer's disease
$1,500,000Lindsay H Burns · Cassava Sciences, Inc · R44 · FY2016 · AG
A Randomized Phase 2A Clinical Trial Pioneering the Utility of an eNAMPT-Reducing Therapy in ARDS/VILI: the PUERTA Trial
$1,500,000Joe G. N. Garcia · Aqualung Therapeutics Corp. · R44 · FY2023 · HL
Yale-SCORE on Sex Differences in Alcohol Use Disorder
$1,500,000Sherry McKee · Yale University · U54 · FY2025 · AA
Inflammation and T Cell Memory: Inter-related Barriers to Allograft Tolerance
$1,500,000Terry B. Strom · Beth Israel Deaconess Medical Center · U19 · FY2010 · DK
A Hub for the Nuclear Receptor Signaling Atlas1
$1,500,000Bert W O'Malley · Baylor College Of Medicine · U24 · FY2012 · DK
Inflammation and T Cell Memory: Inter-related Barriers to Allograft Tolerance
$1,500,000Terry B. Strom · Beth Israel Deaconess Medical Center · U19 · FY2011 · DK
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
$1,500,000Steven E Shoelson · Joslin Diabetes Center · U01 · FY2010 · DK
Miami Center for AIDS Research
$1,500,000Rana Chakraborty · University Of Miami School Of Medicine · P30 · FY2025 · AI
Laboratory Developed Test (LDT) to Support Clinical Evaluation of a Drug for Painful Diabetic Neuropathy
$1,500,000Thomas P Richardson · Plumeria Therapeutics, Inc. · R44 · FY2025 · NS
Inflammation and T Cell Memory: Inter-related Barriers to Allograft Tolerance
$1,500,000Terry B. Strom · Beth Israel Deaconess Medical Center · U19 · FY2007 · DK
SLE Treatment with N-acetylcysteine
$1,500,000Andras Perl · Upstate Medical University · U01 · FY2020 · AR
Inflammation and T Cell Memory: Inter-related Barriers to Allograft Tolerance
$1,500,000Terry B. Strom · Beth Israel Deaconess Medical Center · U19 · FY2009 · DK
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial
$1,499,999Badih Joseph Elmunzer · Medical University Of South Carolina · U01 · FY2020 · DK
Metabolomic and Genetic Factors Decoupling Immune Checkpoint Inhibitor Tumor Efficacy and Cardiovascular Toxicity
$1,499,996Nicolas Palaskas · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · FD
HIV Neurobehavioral Research Center
$1,499,995Robert Kernachan Heaton · University Of California, San Diego · P30 · FY2021 · MH